CELZ (Creative Medical Technology Holdings, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Creative Medical Technology Holdings, Inc. Common Stock (CELZ) is a publicly traded Healthcare sector company. As of May 21, 2026, CELZ trades at $2.26 with a market cap of $8.24M and a P/E ratio of 0.00. CELZ moved +0.00% today. Year to date, CELZ is +11.27%; over the trailing twelve months it is +13.50%. Its 52-week range spans $1.50 to $6.90. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces CELZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns CELZ stock?
Hedge funds tracked by Rallies that own CELZ include Two Sigma and Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Creative Medical Technology Holdings, Inc. Common Stock.
CELZ Key Metrics
Key financial metrics for CELZ
Metric
Value
Price
$2.26
Market Cap
$8.24M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$6.90
52-Week Low
$1.50
Volume
0
Avg Volume
0
Revenue (TTM)
$6.00K
Net Income
$-6.00M
Gross Margin
63.43%
Top Hedge Funds Holding CELZ
Two Sigma holds 14.50K shares of CELZ, changed -3.33% as of Sep 30, 2024.
Two Sigma holds 13.11K shares of CELZ, changed -11.50% as of Sep 30, 2024.
Hedge funds tracked by Rallies that own CELZ include Two Sigma and Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Creative Medical Technology Holdings, Inc. Common Stock.
Does Rallies show 13F holders for CELZ?
Yes. Rallies tracks hedge fund and 13F ownership data for CELZ, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CELZ research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CELZ. It does not provide personalized investment advice.